Managed Healthcare Executive

A preinvasive regulatory T cell axis for lung cancer interception

The surprising new idea that is reshaping how we think about ADHD

Promising therapy for fatty liver disease reduces fat, inflammation, and scarring in preclinical models

Study defines early-onset cirrhosis caused by fatty liver disease - News-Medical

There’s a Vaccine That Could Lower Your Risk of Heart Attack—and Most People Aren’t Getting It

More employers are dropping the largest PBMs

Brazil’s HIV advocates say they predicted USAID funding cuts: ‘We would see the trends’

FDA approves Otsuka’s ADHD drug Simtriyo, teeing up its ‘next major CNS launch’

The FDA has granted approval to Otsuka for Simtriyo, marking the introduction of the first triple reuptake inhibitor for the treatment of ADHD.

Opinion | Cuts to anti-AIDS foreign aid take a toll in Africa

Why Arrowhead Shot Sky-High, While Ionis Toppled

8 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Why your health plan doesn’t cover GLP-1s, according to a top insurance exec

Rising demand for GLP-1 weight-loss medications is straining budgets and prompting insurers and employers to limit coverage.